Life Sciences Cardiovascular Interventional Solutions sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Cardiovascular Interventional Solutions
1.1 - About Life Sciences Cardiovascular Interventional Solutions sector
Companies in Life Sciences Cardiovascular Interventional Solutions design and manufacture devices and therapies that diagnose, repair, and treat cardiac and vascular disorders through minimally invasive and surgical approaches. Offerings span structural heart valves, endovascular aneurysm repair, arrhythmia ablation, vascular reconstruction, and remote cardiac monitoring, helping providers restore hemodynamics, reduce procedural risk, and improve survival. This is a core landscape for M&A analysts researching strategic buyers in cardiovascular devices.
Vendors typically offer transcatheter and surgical heart valve systems, catheter-delivered mitral and tricuspid repair devices, endovascular AAA stent grafts with patient-specific sealing, energy-based cardiac ablation platforms using bipolar RF or pulsed electric fields, and left atrial appendage exclusion solutions applied under direct visualization. They also supply guiding catheters, steerable guidewires, valvulotomes that convert veins to arterial conduits, biologic vascular patches for vessel closure, and ambulatory ECG tools for remote diagnostics.
Primary customers include interventional cardiology teams, cardiac and vascular surgery departments, and hospital cath labs. These companies enable reduced procedural complexity and risk, shorter length of stay, expanded patient eligibility for minimally invasive therapies, and improved long-term outcomes in structural heart and peripheral vascular disease. Buyers also gain more accurate diagnostics, streamlined device navigation, and better resource utilization across integrated health systems.
2. Buyers in the Life Sciences Cardiovascular Interventional Solutions sector
2.1 Top strategic acquirers of Life Sciences Cardiovascular Interventional Solutions companies
Edwards Lifesciences
- Description: Provider of medical device and structural heart disease solutions, developing and manufacturing heart valves, transcatheter mitral and tricuspid therapies, vascular catheters, surgical monitoring and anesthesia technologies that improve patient outcomes in more than 100 countries.
- Key Products:
- Heart Valve Technologies: Designs and produces replacement and repair heart valves that restore cardiac function through minimally invasive or surgical approaches, addressing structural heart disease and improving survival
- Transcatheter Mitral & Tricuspid Therapies: Catheter-based devices delivered via the vasculature to treat mitral and tricuspid valve disorders, reducing the need for open-heart surgery and supporting quicker patient recovery
- Surgical Monitoring and Anesthesia Solutions: Provides intraoperative monitoring and anesthesia systems that deliver real-time hemodynamic data, enhancing clinical decision-making and patient safety during complex procedures
- Vascular and Genuine Fogarty Catheters: Manufactures vascular access and Genuine Fogarty embolectomy catheters used in cardiovascular interventions to manage vessels and support blood flow during surgical treatments.
- Rationale: Provider of Heart Valve Technologies for structural repair, Transcatheter Mitral & Tricuspid Therapies for valve disease, and Fogarty embolectomy catheters.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Cardiovascular Interventional Solutions sector
M&A buyer group 1: Arrhythmia Treatment Devices
AtriCure
- Type: N/A
- Employees: ●●●●●
- Description: Provider of medical device technologies for treating atrial fibrillation and related complications, delivering FDA-approved ablation, left atrial appendage exclusion, hybrid therapy and cryoablation solutions used by electrophysiologists and cardiothoracic surgeons worldwide to improve outcomes and manage post-operative pain.
- Key Products:
- Isolator Synergy Clamps: Bipolar RF surgical clamps that ablate cardiac tissue, creating isolation lesions to treat persistent atrial fibrillation during concomitant coronary bypass or valve repair procedures
- AtriClip LAA Exclusion System: Implantable clip applied under direct visualization to occlude the left atrial appendage during cardiac surgery, eliminating blood flow and lowering stroke risk
- EPi-Sense Coagulation Device: Epicardial RF device used in hybrid convergent procedures to deliver linear lesions for long-standing persistent atrial fibrillation when combined with specified endocardial catheters
- cryoSPHERE Cryoablation Probes: Single-use probes that freeze peripheral or intercostal nerves producing temporary nerve blocks, providing non-opioid post-surgical pain relief for adult and adolescent patients.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Cardiovascular Interventional Solutions sector
3.1 - Buyout funds in the Life Sciences Cardiovascular Interventional Solutions sector
2.2 - Strategic buyer groups for Life Sciences Cardiovascular Interventional Solutions sector
4 - Top valuation comps for Life Sciences Cardiovascular Interventional Solutions companies
4.2 - Public trading comparable groups for Life Sciences Cardiovascular Interventional Solutions sector
Valuation benchmark group 1: Cardiovascular and Electrophysiology Device Manufacturers
Boston Scientific
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of innovative medical solutions, developing and manufacturing medical devices for interventional medical specialties including cardiology, oncology, endoscopy, and neuromodulation, aimed at improving patient health and transforming lives worldwide.
- Key Products:
- Cardiac Devices: Devices for diagnosing and treating heart conditions including stents, pacemakers, and defibrillators
- Oncology Solutions: Minimally invasive medical devices for diagnosing and treating various cancers
- Endoscopy Devices: Tools for diagnosing and treating gastrointestinal and pulmonary conditions
- Neuromodulation Devices: Electronic implantable technologies for managing chronic pain and neurological disorders
- Peripheral Intervention Devices: Technologies for treating peripheral artery and vein conditions.